Cargando…

RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner

Detalles Bibliográficos
Autores principales:	Abdallah, Mohamed Gaber, Niibori-Nambu, Akiko, Morii, Mariko, Yokomizo, Takako, Yokomizo, Tomomasa, Ideue, Takako, Kubota, Sho, Teoh, Vania Swee Imm, Mok, Michelle Meng Huang, Wang, Chelsia Qiuxia, Omar, Abdellah Ali, Tokunaga, Kenji, Iwanaga, Eisaku, Matsuoka, Masao, Asou, Norio, Nakagata, Naomi, Araki, Kimi, AboElenin, Mabrouk, Madboly, Sayed Hamada, Sashida, Goro, Osato, Motomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478654/ https://www.ncbi.nlm.nih.gov/pubmed/34148054 http://dx.doi.org/10.1038/s41375-021-01268-4

Ejemplares similares

Unique N-terminal sequences in two Runx1 isoforms are dispensable for Runx1 function
por: Nieke, Sebastian, et al.
Publicado: (2017)

Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
por: Kubota, Sho, et al.
Publicado: (2019)

Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
por: Kubota, Sho, et al.
Publicado: (2019)

Runx1 is required for the endothelial to hematopoietic cell transition but not thereafter
por: Chen, Michael J., et al.
Publicado: (2009)

MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO
por: Kohrs, Nicole, et al.
Publicado: (2016)

RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
por: Loke, Justin, et al.
Publicado: (2017)

RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
por: van der Kouwe, Emiel, et al.
Publicado: (2019)

RUNX1 and its fusion oncoprotein derivative RUNX1-ETO induce senescence-like growth arrest independently of replicative stress
por: Wolyniec, Kamil, et al.
Publicado: (2009)

RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity
por: Chin, D W L, et al.
Publicado: (2016)

The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype
por: Forster, V J, et al.
Publicado: (2016)

The RUNX Family, a Novel Multifaceted Guardian of the Genome
por: Dutta, Bibek, et al.
Publicado: (2023)

Transcription Factors Runx1 and Runx3 Suppress Keratin Expression in Undifferentiated Keratinocytes
por: Ogawa, Eisaku, et al.
Publicado: (2022)

RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1
por: Ponnusamy, K, et al.
Publicado: (2015)

The RUNX1 Enhancer Element eR1: A Versatile Marker for Adult Stem Cells
por: Chuang, Linda Shyue Huey, et al.
Publicado: (2020)

The RUNX1/RUNX1T1 network: translating insights into therapeutic options
por: Swart, Laura E., et al.
Publicado: (2021)

Prognostic Impacts of D816V KIT Mutation and Peri-Transplant RUNX1–RUNX1T1 MRD Monitoring on Acute Myeloid Leukemia with RUNX1–RUNX1T1
por: Cho, Byung-Sik, et al.
Publicado: (2021)

RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia
por: Grinev, Vasily V., et al.
Publicado: (2021)

A DNA Contact Map for the Mouse Runx1 Gene Identifies Novel Haematopoietic Enhancers
por: Marsman, Judith, et al.
Publicado: (2017)

Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity
por: Weng, Stephanie, et al.
Publicado: (2016)

Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21)
por: Lu, Lianghao, et al.
Publicado: (2018)

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation
por: Martinez-Soria, Natalia, et al.
Publicado: (2018)

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation
por: Martinez-Soria, Natalia, et al.
Publicado: (2019)

Thrombospondin-1 Is a Putative Target Gene of Runx2 and Runx3
por: Shi, Xiuming, et al.
Publicado: (2013)

RUNX1 and breast cancer
por: Mercado-Matos, Jose, et al.
Publicado: (2017)

Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/RUNX1-RUNX1T1 Rearrangement
por: Tokunaga, Kenji, et al.
Publicado: (2017)

Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion
por: Yun, Jae Won, et al.
Publicado: (2019)

Volunteer unrelated donor cell‐derived acute myeloid leukemia with RUNX1‐RUNX1T1
por: Hagiwara, Shinya, et al.
Publicado: (2021)

Functional Characterization of Cooperating MGA Mutations in RUNX1::RUNX1T1 Acute Myeloid Leukemia
por: Klco, Jeffery, et al.
Publicado: (2023)

Hemophagocytic Lymphohistiocytosis in RUNX1::RUNX1T1 Positive AML with Blast Count Below 20%
por: Huang, Xingqin, et al.
Publicado: (2023)

Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
por: Hornung, Roman, et al.
Publicado: (2018)

Integrative analysis of RUNX1 downstream pathways and target genes
por: Michaud, Joëlle, et al.
Publicado: (2008)

Hepatic leukemia factor-expressing paraxial mesoderm cells contribute to the developing brain vasculature
por: Koui, Yuta, et al.
Publicado: (2022)

Interference with RUNX1/ETO Leukemogenic Function by Cell-Penetrating Peptides Targeting the NHR2 Oligomerization Domain
por: Bartel, Yvonne, et al.
Publicado: (2013)

Expression of RUNX1-ETO Rapidly Alters the Chromatin Landscape and Growth of Early Human Myeloid Precursor Cells
por: Nafria, Monica, et al.
Publicado: (2020)

Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects
por: Gopalswamy, Mohanraj, et al.
Publicado: (2022)

Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia
por: Issa, Hasan, et al.
Publicado: (2023)

Pseudo-Chediak-Higashi granules in myeloid cells in therapy-related AML with RUNX1-RUNX1T1
por: Cho, Sung Ran, et al.
Publicado: (2018)

Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1
por: Shaikh, Anam Fatima, et al.
Publicado: (2020)

Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid Leukemia with RUNX1::RUNX1T1
por: Hwang, Sang Mee, et al.
Publicado: (2022)

The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy
por: Homan, Claire C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a53c6fo8vfhok7lc6sc6ri2is0